Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKER

Akers Biosciences (AKER) Stock Price, News & Analysis

Akers Biosciences logo

About Akers Biosciences Stock (NASDAQ:AKER)

Advanced Chart

Key Stats

Today's Range
$0.08
$0.09
50-Day Range
$2.47
$4.59
52-Week Range
$1.65
$6.97
Volume
40.31 million shs
Average Volume
769,876 shs
Market Capitalization
$1.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AKER Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Cam Akers Not Worth A Look In Week 10
See More Headlines

AKER Stock Analysis - Frequently Asked Questions

Akers Biosciences, Inc. (NASDAQ:AKER) announced its quarterly earnings data on Thursday, November, 15th. The medical instruments supplier reported ($0.26) EPS for the quarter. The medical instruments supplier earned $0.56 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akers Biosciences investors own include Sorrento Therapeutics (SRNE), Aytu BioPharma (AYTU), ImmunoGen (IMGN), AVEO Pharmaceuticals (AVEO), Advanced Micro Devices (AMD), Vaxart (VXRT) and Neovasc (NVCN).

Company Calendar

Last Earnings
11/15/2018
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:AKER
CIK
1321834
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.89 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.42%
Return on Assets
-73.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.22
Quick Ratio
9.22

Sales & Book Value

Annual Sales
$1.58 million
Price / Sales
1.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.38 per share
Price / Book
0.02

Miscellaneous

Outstanding Shares
16,653,000
Free Float
N/A
Market Cap
$1.58 million
Optionable
Not Optionable
Beta
0.30
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:AKER) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners